Journals / Haseki Tıp Bülteni / 2017 / Cilt: 55 - Sayı: 4

Lokal İleri Mide Kanserinde Multivisseral Rezeksiyonun Hasta Sağlığı ve Sağkalımı Üzerine Etkisi

Effect of Multivisceral Resection on Health Status and Survival of Patients with Locally Advanced Gastric Cancer

Pages
254–260
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion:­Multivisceral resection in patients in whom R0 resection is possible, in those with a platelet/lymphocyte ratio of <130, neutrophil/ lymphocyte ratio of <2.4, and with fewer than six metastatic lymph nodes, may provide increased survival periods without additional morbidity burden in experienced hands.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Gastric cancer is the fifth most common cancer and the second leading cause of cancer-related deaths.
📊
Key Findings & Data:Methods:­The prospectively recorded data of 445 operated patients in the General Surgery Clinic at Dokuz Eylül University due to gastric cancer were reviewed.
💡
Conclusion & Impact:Conclusion:­Multivisceral resection in patients in whom R0 resection is possible, in those with a platelet/lymphocyte ratio of <130, neutrophil/ lymphocyte ratio of <2.4, and with fewer than six metastatic lymph nodes, may provide increased survival periods without additional morbidity burden in experienced hands.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: Gastric cancer is the fifth most common cancer and the second leading cause of cancer-related deaths. Adjacent organ invasion is frequently observed in cases of gastric cancer which is often diagnosed in advanced stages in the Western countries. It is aimed to evaluate the effects of gastrectomy with multivisceral resection on health status and survival of patients with locally advanced gastric cancer. Methods:­The prospectively recorded data of 445 operated patients in the General Surgery Clinic at Dokuz Eylül University due to gastric cancer were reviewed. A total of 164 patients with locally invasive tumor detected during laparotomy or those in pT4 status according to post-resection pathologic staging were included in the study. Results: One hundred and twenty patients underwent gastrectomy, 24 patients underwent gastrectomy with multivisceral resection, and 20 patients underwent palliative procedure. The patient groups were compared for demographic data, tumor location, preoperative biochemical analysis, hemoglobin values, and survival. The patients with palliative procedures were found to be significantly disadvantaged in terms of survival. There were no differences in the rates of R0 resection and postoperative complication between multivisceral resection group and only gastrectomy group. It was determined that survival of patients with multivisceral resection was significantly longer than palliative surgery patients. Conclusion:­Multivisceral resection in patients in whom R0 resection is possible, in those with a platelet/lymphocyte ratio of <130, neutrophil/ lymphocyte ratio of <2.4, and with fewer than six metastatic lymph nodes, may provide increased survival periods without additional morbidity burden in experienced hands.

Özet

Amaç: Mide kanseri görülme sıklığı açısından beşinci, kanser kaynaklı ölüm açısından ise ikinci sırada yer almaktadır. Batı ülkelerinde çoğunlukla ileri evrede tanı alan mide kanser olgularında çevre organ invazyonu sık rastlanan bir durumdur. Çalışmamızda lokal ileri evredeki mide kanseri olgularında multivisseral rezeksiyonun hasta sağlığı ve sağkalımı üzerine etkilerinin gözden geçirilmesi amaçlanmaktadır. Yöntemler: Mide kanseri nedeniyle Dokuz Eylül Üniversitesi Genel Cerrahi Kliniği'nde ameliyat edilmiş 445 hastanın prospektif kayıt altına alınmış olan verileri incelendi. Laparotomi esnasında çevre organ/yapı invazyonu gösteren ya da rezeksiyon sonrası patolojik evrelemede pT4 evresinde olan toplam 164 hasta çalışmaya dahil edildi. Bulgular: Yüz yirmi hastaya gastrektomi, 24 hastaya multivisseral rezeksiyon ile gastrektomi, 20 hastaya palyatif işlem yapıldığı görüldü. Hasta grupları karşılaştırıldıklarında demografik verileri, tümör yerleşimi, ameliyat öncesi kan biyokimyasal analizleri ve hemoglobin değerleri açısından farklılık saptanmazken, palyatif işlem yapılan hastaların sağkalım açısından oldukça dezavantajlı oldukları belirlendi. Multivisseral rezeksiyon grubu ile sadece gastrektomi yapılan grup arasında R0 rezeksiyon ve postoperatif komplikasyon oranları açısından farklılık saptanmadı. Multivisseral rezeksiyon yapılan hastaların sağkalımlarının palyatif işleme göre anlamlı süre uzamış olduğu belirlendi. Sonuç: Altıdan daha az sayıda metastatik lenf nodu olan, platelet/ lenfosit oranı <130, nötrofil/lenfosit oranı <2,4 saptanan, R0 rezeksiyonun mümkün olduğu olgularda multivisseral rezeksiyon, tecrübeli ellerde ek morbidite yükü oluşturmadan sağkalım sürelerinde artış sağlayabilir.

🔖

Cite This Article

DERİCİ, Z. S., ATİLLA, K., SARIOĞLU, S., BORA, S. (2017). Lokal İleri Mide Kanserinde Multivisseral Rezeksiyonun Hasta Sağlığı ve Sağkalımı Üzerine Etkisi. Haseki Tıp Bülteni, Cilt: 55 - Sayı: 4, 254–260. https://ajindex.com/articles/201442

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:359-86
  2. Strong VE, Song KY, Park CH, et al. Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram. Ann Surg 2010;251:640-6
  3. Biondi A, Persiani R, Cananzi F, et al. R0 resection in the treatment of gastric cancer: Room for improvement. World J Gastroenterol 2010;16:3358-70
  4. Saito H, Tsujitani S, Maeda Y, et al. Combined resection of invaded organs in patients with T4 gastric carcinoma. Gastric Cancer 2001;4:206-11
  5. Jeong O, Choi WY, Park YK. Appropriate selection of patients for combined organ resection in cases of gastric carcinoma invading adjacent organs. J Surg Oncol 2009;100:115-20
  6. Brar SS, Seevaratnam R, Cardoso R, et al. Multivisceral resection for gastric cancer: a systematic review. Gastric Cancer 2012;15(Suppl 1):100-7
  7. Tran TB, Worhunsky DJ, Norton JA, et al. Multivisceral Resection for Gastric Cancer: Results from the US Gastric Cancer Collaborative. Ann Surg Oncol 2015;22(Suppl 3):840-7
  8. Mita K, Ito H, Fukumoto M, et al. Surgical outcomes and survival after extended multiorgan resection for T4 gastric cancer. Am J Surg 2012;203:107-11
  9. Carboni F, Lepiane P, Santoro R, et al. Extended multiorgan resection for T4 gastric carcinoma: 25-Year experience. J Surg Oncol 2005;90:95-100
  10. Zhou X, Du Y, Huang Z, et al. Prognostic value of PLR in various cancers: a meta-analysis. PLoS One 2014;9:e1101119
  11. Jung MR, Park YK, Jeong O, Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancer. J Surg Oncol 2011;104:504-10
  12. Deng Q, He B, Liu X, et al. Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model. J Transl Med 2015;13:66
  13. Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 2009;250:187-96
  14. Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006;355:11-20
  15. Hirakawa M, Sato Y, Ohnuma H, et al. A phase II study of neoadjuvant combination chemotherapy with docetaxel, cisplatin, and S-1 for locally advanced resectable gastric cancer: nucleotide e